Final results of a phase II study of everolimus (RAD001) in metastatic transitional cell carcinoma (TCC) of the urothelium.
M. I. Milowsky
Research Funding - Novartis
A. M. Regazzi
No relevant relationships to disclose
I. R. Garcia-Grossman
No relevant relationships to disclose
A. Trout
No relevant relationships to disclose
A. Flaherty
No relevant relationships to disclose
S. Gerst
No relevant relationships to disclose
H. Al-Ahmadie
No relevant relationships to disclose
I. Ostrovnaya
No relevant relationships to disclose
D. F. Bajorin
Consultant or Advisory Role - Bristol-Myers Squibb; Dendreon; GlaxoSmithKline
Honoraria - Lilly
Research Funding - Amgen; Genentech; Genta